Continue active refreshing of this index's data?
Continue active refreshing of this index's data?
About 364 results found
In “An Aussie sense of style”, Axioma’s latest paper on smart beta products, we take a look at the inherent compromise between delivering target factor purity versus maximizing factor exposure.
After a bumper year for equities, strategists are forecasting further gains for 2018, while pointing to risks from rising bond yields and higher volatility.
The post-crisis economic recovery gathered pace in 2017 as the Eurozone and Japan joined the global growth momentum, helping investors push risk assets higher.
Whether it's optimizers of patient treatment or hybrid bio-chemical drugs, many health-care stocks are inventing the future.